HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Homer Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

10/2014Cathepsin E promotes pulmonary emphysema via mitochondrial fission.
8/2006State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Homer Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 10/2008
5Asthma (Bronchial Asthma)
04/2018 - 08/2006
3Lung Neoplasms (Lung Cancer)
01/2020 - 10/2008
3Fibrosis (Cirrhosis)
02/2017 - 06/2010
3Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2017 - 07/2004
3Infections
12/2012 - 10/2008
3Eosinophilia
12/2012 - 10/2008
3Inflammation (Inflammations)
10/2011 - 01/2007
3Pneumonia (Pneumonitis)
06/2011 - 01/2007
3Lung Injury
01/2008 - 04/2005
2Sarcoidosis (Schaumann Disease)
01/2022 - 02/2017
2Adenocarcinoma of Lung
01/2021 - 01/2020
2Idiopathic Pulmonary Fibrosis
01/2020 - 12/2017
2Chronic Obstructive Pulmonary Disease (COPD)
10/2014 - 08/2006
2Emphysema
10/2014 - 08/2006
2Acute Lung Injury
06/2010 - 04/2005
2Hyperoxia
10/2005 - 04/2005
1Choriocarcinoma
01/2019
1Hyperglycemia
04/2018
1Dyspnea (Shortness of Breath)
04/2018
1Lymphadenopathy
04/2018
1Pulmonary Sarcoidosis
04/2018
1Weight Loss (Weight Reduction)
04/2018
1Noonan Syndrome (Female Pseudo-Turner Syndrome)
02/2017
1Airway Obstruction (Choking)
02/2017
1Lung Diseases (Lung Disease)
10/2014
1Pulmonary Emphysema
10/2014
1Metaplasia
12/2012
1Interstitial Lung Diseases (Interstitial Lung Disease)
08/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2008
1Human Influenza (Influenza)
01/2008
1Melanoma (Melanoma, Malignant)
10/2007
1Blister (Bulla)
06/2007

Drug/Important Bio-Agent (IBA)

5CytokinesIBA
01/2022 - 04/2005
4Proteins (Proteins, Gene)FDA Link
10/2014 - 04/2005
3Tyrosine Kinase InhibitorsIBA
01/2021 - 10/2019
2osimertinibIBA
01/2021 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2020 - 12/2017
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 10/2019
2Prednisone (Sone)FDA LinkGeneric
04/2018 - 02/2017
2Bleomycin (Blenoxane)FDA LinkGeneric
02/2017 - 06/2010
2Interleukin-13IBA
12/2012 - 01/2007
2ChitinasesIBA
10/2011 - 11/2008
2ChemokinesIBA
06/2010 - 10/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2006 - 04/2005
2Oxidants (Oxidizing Agents)IBA
10/2005 - 04/2005
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2022
1LectinsIBA
01/2022
1GlucocorticoidsIBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2022
1Janus Kinase InhibitorsIBA
01/2022
1tofacitinibIBA
01/2022
1AfatinibIBA
01/2020
1ErbB Receptors (EGF Receptor)IBA
10/2019
1Insulin (Novolin)FDA Link
04/2018
1Formaldehyde (Formol)FDA Link
12/2017
1ParaffinIBA
12/2017
1AntibodiesIBA
08/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2017
1Therapeutic UsesIBA
02/2017
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2017
1Dynamins (Dynamin)IBA
10/2014
1Peptide Hydrolases (Proteases)FDA Link
10/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
10/2014
1SmokeIBA
10/2014
1CaspasesIBA
10/2014
1Cathepsin EIBA
10/2014
1CathepsinsIBA
10/2014
1Cysteine (L-Cysteine)FDA Link
10/2014
1Interleukin-5 (Interleukin 5)IBA
12/2012
1Pharmaceutical PreparationsIBA
10/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2011
1IntegrinsIBA
08/2011
1Semaphorins (Semaphorin)IBA
08/2011
1Syndecan-4IBA
06/2010
1GlycosaminoglycansIBA
06/2010
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
06/2010
1Heparin (Liquaemin)FDA LinkGeneric
06/2010
1indium-bleomycinIBA
06/2010
1MicroRNAs (MicroRNA)IBA
10/2008
1Genetic Markers (Genetic Marker)IBA
10/2008
13' Untranslated Regions (3' UTR)IBA
10/2008
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2008
1Interferon-gamma (Interferon, gamma)IBA
10/2008
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2008
1Interleukin-4 (Interleukin 4)IBA
10/2008
1Interleukin-12 (IL 12)IBA
10/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008
1Chemokine CCL4IBA
10/2008
1Messenger RNA (mRNA)IBA
10/2008
1LigandsIBA
01/2008
1Antiviral Agents (Antivirals)IBA
01/2008
1MART-1 AntigenIBA
10/2007

Therapy/Procedure

7Therapeutics
01/2021 - 06/2010
2Immunotherapy
01/2022 - 10/2019
1Aftercare (After-Treatment)
01/2019
1Tracheostomy
02/2017
1Mechanical Ventilators (Ventilator)
06/2011
1Ligation
01/2008
1Thoracotomy
06/2007